Pro-erectile Effect of Vardenafil: In Vitro Experiments in Rabbits and In Vivo Comparison with Sildenafil in Rats

European Urology

Volumn 44, Issue 6, 2003, Pages 731-736

  Giuliano, F ^a,b,d   Bernabe, J ^a   Alexandre, L ^b   Niewoehner, U ^c   Haning, H ^c   Bischoff, E ^c  

^a CNRS   (France)

^b School of Medicine   (France)

^c BAYER AG   (Germany)

^d BICÊTRE HOSPITAL   (France)

Author keywords

Corpus cavernosum; Erectile dysfunction; In vitro; In vivo; PDE5 inhibitor; Penile erection; Pharmacology; Rabbits; Rats; Sildenafil; Vardenafil

Indexed keywords

N(G) NITROARGININE METHYL ESTER; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; SODIUM CHLORIDE; VARDENAFIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RABBIT; RAT; REVIEW;

EID: 0346905434     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00377-4     Document Type: Article

References (10)

1. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990;170:843-50.
2. Burnett AL. Role of nitric oxide in the physiology of erection. Biol Reprod 1995;52:485-9.
3. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8:47-52.
4. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338:1397-404.
5. Saenz de Tejada I, Angulo J, Cuevas P, Fernández A, Moncada I, Allona A, et al. The phosphodiesterase inhibitory selectivity and in vivo potency of the new PDE5 inhibitor vardenafil. Int J Impot Res 2001;13:282-90.
6. Chuang AT, Strauss JD, Murphy RA, Steers WD. Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 1998;160:257-61.
7. Stief CG, Uckert S, Becker AJ, Truss MC, Jonas U. The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol 1998;159: 1390-3.
8. Chen KK, Chan JY, Chang LS, Chen MT, Chan SH. Intracavernous pressure as an experimental index in a rat model for the evaluation of penile erection. J Urol 1992;147:1124-8.
9. Giuliano F, Bernabe J, Jardin A, Rousseau JP. Antierectile role of the sympathetic nervous system in rats. J Urol 1993;150:519-24.
10. Choi S, O'Connell L, Min K, Kim NN, Munarriz R, Goldstein I, et al. Efficacy of vardenafil and sildenafil in facilitating penile erection in an animal model. J Androl 2002;23(3):332-7.